Spring Creek Capital’s AEON Biopharma Inc AEON.WS Stock Holding History

Spring Creek Capital’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-83,333	Closed	-$26K	–	263
2022 Q1	$26K	Hold	83,333	–	–	﹤0.01%	672
2021 Q4	$42K	Hold	83,333	–	–	﹤0.01%	574
2021 Q3	$46K	Hold	83,333	–	–	﹤0.01%	480
2021 Q2	$83K	Buy	+83,333	New	+$63.3K	﹤0.01%	442

Other funds holding AEON.WS

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return

Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Spring Creek Capital's AEON.WS Position: Q2 2022 in Review

Spring Creek Capital sold out of AEON Biopharma Inc (AEON.WS) in Q2 2022, closing a stake of 83,333 shares — an estimated $26K sold.

Spring Creek Capital first reported a position in AEON.WS in Q2 2021 and held it in 4 quarters. The position peaked at $83K in Q2 2021. 52 funds tracked by Wall St. Rank hold AEON.WS as of Q2 2022.

Spring Creek Capital reported no remaining AEON Biopharma Inc position as of Q2 2022 after selling out during the quarter.
Spring Creek Capital sold 83,333 AEON Biopharma Inc shares in Q2 2022, an estimated $26K.
Spring Creek Capital first reported a position in AEON Biopharma Inc in Q2 2021 and held it in 4 quarters.
Spring Creek Capital's AEON Biopharma Inc position peaked at $83K in Q2 2021.
52 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q2 2022.

Based on Spring Creek Capital's 13F filing for Q2 2022.